Similar articles for PMID: 31432151

Year	Number of Results
2002	1
2003	4
2005	2
2006	5
2007	1
2008	2
2011	2
2012	3
2013	3
2014	7
2015	13
2016	13
2017	10
2018	10
2019	8
2020	3
2021	1
2022	1
2024	0

1

Zhang S, Mo Q, Wang X. Zhang S, et al. Int J Oncol. 2019 Oct;55(4):775-788. doi: 10.3892/ijo.2019.4856. Epub 2019 Aug 13. Int J Oncol. 2019. PMID: 31432151 Review.

2

Regulation of transcription factor Twist expression by the DNA architectural protein high mobility group A2 during epithelial-to-mesenchymal transition.

Tan EJ, Thuault S, Caja L, Carletti T, Heldin CH, Moustakas A. Tan EJ, et al. J Biol Chem. 2012 Mar 2;287(10):7134-45. doi: 10.1074/jbc.M111.291385. Epub 2012 Jan 11. J Biol Chem. 2012. PMID: 22241470 Free PMC article.

3

HMGA2 as a Critical Regulator in Cancer Development.

Mansoori B, Mohammadi A, Ditzel HJ, Duijf PHG, Khaze V, Gjerstorff MF, Baradaran B. Mansoori B, et al. Genes (Basel). 2021 Feb 13;12(2):269. doi: 10.3390/genes12020269. Genes (Basel). 2021. PMID: 33668453 Free PMC article. Review.

4

Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.

Shi Z, Li X, Wu D, Tang R, Chen R, Xue S, Sun X. Shi Z, et al. Tumour Biol. 2016 Jun;37(6):7515-23. doi: 10.1007/s13277-015-4625-2. Epub 2015 Dec 18. Tumour Biol. 2016. PMID: 26684800

5

STC2 overexpression mediated by HMGA2 is a biomarker for aggressiveness of high-grade serous ovarian cancer.

Wu J, Lai M, Shao C, Wang J, Wei JJ. Wu J, et al. Oncol Rep. 2015 Sep;34(3):1494-502. doi: 10.3892/or.2015.4120. Epub 2015 Jul 9. Oncol Rep. 2015. PMID: 26165228 Free PMC article.

6

High-mobility group A2 overexpression is an unfavorable prognostic biomarker for nasopharyngeal carcinoma patients.

Liu Z, Wu K, Yang Z, Wu A. Liu Z, et al. Mol Cell Biochem. 2015 Nov;409(1-2):155-62. doi: 10.1007/s11010-015-2521-0. Epub 2015 Jul 17. Mol Cell Biochem. 2015. PMID: 26183485

7

miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.

Ma J, Li D, Kong FF, Yang D, Yang H, Ma XX. Ma J, et al. J Exp Clin Cancer Res. 2018 Feb 1;37(1):19. doi: 10.1186/s13046-018-0686-6. J Exp Clin Cancer Res. 2018. PMID: 29391048 Free PMC article.

8

HMGA2 and Bach-1 cooperate to promote breast cancer cell malignancy.

Mansoori B, Mohammadi A, Asadzadeh Z, Shirjang S, Minouei M, Abedi Gaballu F, Shajari N, Kazemi T, Gjerstorff MF, Duijf PHG, Baradaran B. Mansoori B, et al. J Cell Physiol. 2019 Aug;234(10):17714-17726. doi: 10.1002/jcp.28397. Epub 2019 Mar 1. J Cell Physiol. 2019. PMID: 30825204

9

Gene Expression Signature-Based Approach Identifies Antifungal Drug Ciclopirox As a Novel Inhibitor of HMGA2 in Colorectal Cancer.

Huang YM, Cheng CH, Pan SL, Yang PM, Lin DY, Lee KH. Huang YM, et al. Biomolecules. 2019 Nov 2;9(11):688. doi: 10.3390/biom9110688. Biomolecules. 2019. PMID: 31684108 Free PMC article.

10

HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.

Li Y, Zhao Z, Xu C, Zhou Z, Zhu Z, You T. Li Y, et al. Cancer Lett. 2014 Dec 1;355(1):130-40. doi: 10.1016/j.canlet.2014.09.007. Epub 2014 Sep 11. Cancer Lett. 2014. PMID: 25218351

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

81 results

Results by year